November 22, 2017
Nordic Nanovector ASA – Results for the Third Quarter 2017
Media
November 20, 2017
Zubsolv® receives authorization for treatment of opioid dependence in Europe
November 16, 2017
Wilson Therapeutics to host conference call to provide third quarter 2017 business update
November 14, 2017
Strongbridge Biopharma plc Provides Corporate Update and Reports Third Quarter 2017 Financial Results
November 14, 2017
Bonesupport – Cerament® G’s potential to prevent and manage biofilm-related bone infections highlighted in new high-profile publication
November 14, 2017
Targovax to present at upcoming investor conferences
November 13, 2017
Nexstim gains FDA clearance to commercialise its NBT® system in the US for the treatment of depression
November 13, 2017
Nordic Nanovector to Present at Jefferies Global Healthcare Conference
November 13, 2017
Q3 2017 General Market Overview
November 09, 2017
Wilson Therapeutics’ Nomination Committee appointed